Clinical Trial Update: Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML [Phase 1]

View source ↗

Summary

Phase I dose-escalation study of volasertib in combination with azacitidine in patients with myelodysplastic syndromes or chronic myelomonocytic leukemia. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Volasertib (Volasertib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic | Phase 1 | Status: TERMINATED | Results posted: 2019-02-08